News
The FDA warns that longtime users of popular allergy medications may experience "severe itching" after stopping use.
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy ...
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
The agency will require manufacturers to add a warning to prescription and OTC labeling about the risk of itching and the ...
The Food and Drug Administration (FDA) announced Wednesday plans to help states and Indian tribes import cheaper prescription ...
Johnson & Johnson has won the support of an FDA expert panel in its bid to make Darzalex the first treatment for an early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results